Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0007 USD | 0.00% | 0.00% | -99.98% |
2023 | Statera Biopharma, Inc. entered into a letter of intent to acquire Worksite Labs. | CI |
2023 | Statera Biopharma, Inc.(OTCPK:STAB) dropped from S&P TMI Index | CI |
Financials (USD)
Sales 2020 | - | Sales 2021 | 1.49 | Capitalization | 73.82M |
---|---|---|---|---|---|
Net income 2020 | -12M | Net income 2021 | -102M | EV / Sales 2020 * | - |
Net Debt 2020 | 1.41M | Net Debt 2021 | 14.28M | EV / Sales 2021 | 59,246,379 x |
P/E ratio 2020 * |
-
| P/E ratio 2021 |
-0.79
x | Employees | 46 |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
Current month | -99.98% | ||
Current year | -99.98% |
Managers | Title | Age | Since |
---|---|---|---|
Yakov Kogan
FOU | Founder | 50 | 03-06-04 |
Andrei V. Gudkov
FOU | Founder | 66 | 03-06-04 |
Michael Handley
CEO | Chief Executive Officer | 52 | 21-07-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
John A. Kallassy
BRD | Director/Board Member | 59 | 22-09-01 |
Uday Saxena
BRD | Director/Board Member | 66 | 22-06-16 |
Michael Handley
CEO | Chief Executive Officer | 52 | 21-07-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 0.0007 | 0.00% | 1 510 |
24-05-14 | 0.0007 | 0.00% | 5,384 |
24-05-13 | 0.0007 | 0.00% | 1,331 |
24-05-10 | 0.0007 | 0.00% | 455 |
24-05-09 | 0.0007 | 0.00% | 274 |
Delayed Quote Nasdaq, May 15, 2024 at 01:54 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+28.87% | 49.18B | |
+0.89% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.30% | 26.09B | |
-22.53% | 18.71B | |
+8.16% | 13.26B | |
+32.17% | 12.32B | |
-0.45% | 11.99B |
- Stock Market
- Equities
- STAB Stock
- STAB Stock